Education Research Current About VU Amsterdam NL
Bachelor's programmes Master's programmes VU for Professionals
Exchange programme VU Amsterdam Summer School Honours Programme Dutch language courses (NT2) Semester in Amsterdam
PhD at VU Amsterdam Featured research Prizes and distinctions
Interdisciplinary research institutes Scientists of VU Amsterdam Research Impact Support Portal Create impact with your research
News Events calendar Moving towards a healthier future
VU UPDATE: Situation in Israel and the Palestinian regions Culture at VU Amsterdam
Practical matters Mission, core values and vision Entrepreneurship on VU Campus
Governance of VU Amsterdam Valorisation and impact Partnering with VU Amsterdam VU Alumni Community Take a look at our vacancies!
Sorry! De informatie die je zoekt, is enkel beschikbaar in het Engels.
This programme is saved in My Study Choice.
Something went wrong with processing the request.
Something went wrong with processing the request.

Brain research with psychedelic substances

Share
13 January 2025

The brains of people under the influence of psilocybin, the active compound in psychedelic “magic” mushrooms and truffles, respond fundamentally differently to visual stimuli. This discovery was made by neuroscientist Marco Aqil. Until now, no neuroscientific research involving psychedelic substances had been conducted in Amsterdam.

Aqil is fascinated by the human brain and how psychedelic substances affect it. The neuroscientist combined these interests in his research on how our brains respond to visual stimuli. First, he developed a mathematical model able to capture a variety of brain responses with a single equation.

He then turned his focus to his other fascination: the effects of psychedelic substances on the brain. “Although Amsterdam is home to countless smartshops selling psychedelic “magic truffles”, no scientific research on these substances had ever been done here” says the Italian scientist. This was no easy task. While truffles are legal, psilocybin itself is illegal, and the study had to meet stringent medical and ethical standards. Eventually, twenty individuals with prior experience with psychedelics were selected for the research.

During the study, all participants underwent three sessions in which they were administered placebo, 5 milligrams, and 10 milligram of psilocybin in random order. While inside an MRI scanner, they performed visual tests. The findings revealed that participants who had taken psilocybin displayed different brain responses. “We observed that visual surround suppression was diminished by psilocybin. Normally, brain responses to visual stimuli are suppressed by stimuli presented in the surround. In other words, they undergo a contextual, suppressive modulation. But under psilocybin, this effect was reduced. We saw altered brain activity in the visual system.”

This aligns with anecdotal reports from users of these substances, who often describe experiencing “freer thoughts” and more associative, less suppressed thinking. According to Aqil, the study demonstrates that psychedelics alter how the brain functions in very fundamental ways. “It contributes to a broader understanding of what these substances, which are increasingly used in psychological treatments, actually do in the human brain.”

Marco Aqil defends his PhD January 23th.

Foto: Natasha Connell 

Quick links

Homepage VU Amsterdam Culture at VU Amsterdam University Library Dashboard

Study

Academic calendar Study Guide Timetable Canvas

Featured

Donate to the VU Fund VU Magazine Ad Valvas Digital accessibility

About VU Amsterdam

Contact with VU Amsterdam Take a look at our vacancies! Faculties VU Amsterdam Divisions VU Amsterdam
Privacy Disclaimer Safety Web Colophon Cookie settings Web Archive

Copyright © VU